Tercica Gives Ipsen US Foothold

Ipsen's July 2006 tie-up with Tercica achieves a triple objective for the French group: a US partner for acromegaly drug Somatuline Autogel, a quid for Europe, and a bridgehead into the US. Tercica gets a second product to sell, a pipeline, and a likely buyer.